[Antiblastic chemotherapy and immunity in childhood].
D000818:Animals; D000937:Antigen-Antibody Reactions / Q000187:drug effects*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D005260:Female; D006689:Hodgkin Disease / Q000188:drug therapy; D006801:Humans; D007136:Immunoglobulins / Q000096:biosynthesis; D007223:Infant; D007938:Leukemia / Q000188:drug therapy* / Q000276:immunology; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy; D008297:Male; D009369:Neoplasms / Q000188:drug therapy* / Q000276:immunology; D009447:Neuroblastoma / Q000188:drug therapy; D009396:Wilms Tumor / Q000188:drug therapy; D005719:gamma-Globulins / Q000096:biosynthesis*
D000970:Antineoplastic Agents; D007136:Immunoglobulins; D005719:gamma-Globulins
Chemioterapia antiblastica ed immunità nell'infanzia.